As of August 2015, Paul L. Smock is serving as the interim director for Mount St. Mary’s University’s Master of Science in Biotechnology and Management Program (MSB). In addition to his new role at MSMU, Smock also works as a biotechnology quality and technical consultant for Meridian BioGroup, LLC. The MSB is an interdisciplinary graduate program that emphasizes both science and business components.
Smock has 38 years of experience in the biotechnology industry, spanning biopharmaceuticals, vaccines, validation consulting, and the in-vitro diagnostic businesses. Previously, Smock was senior director, technical quality at AstraZeneca Biologics and held the position of senior director, quality assurance for the Frederick Manufacture Center for the start-up, licensure and transition to multi-product clinical/commercial operations phases of this facility, starting in 2010. He has also held both technical and management positions in QA/QC, validation, process development, and production at Wyeth Biotech, Serono Laboratories, Triad Technologies, and the DuPont Company.
Smock is a 20-year member of the International Society for Pharmaceutical Engineering (ISPE), Past President of the Boston Area Chapter of ISPE, active with the BioPhorum Operation Group (BPOG), and a frequent speaker at Biopharmaceutical conferences. He holds a B.S. in Chemistry/Mathematics from the University of Michigan, and a Master of Clinical Chemistry from the University of Dayton.
Classes for the MSB are hosted at MSMU’s Frederick Campus. The program is designed for the working adult with one night a week evening courses from 6-9:30 p.m. For more information, visit msmary.edu/biotech.